Sionna Therapeutics (SION) Earnings Analysis

Sionna Therapeutics (SION) next reports earnings on 2026-08-10, consensus EPS -0.64 USD. Last quarter (2026-03-02) it beat with EPS -0.46 USD vs -0.539 USD est (+14.7%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -23.33.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SION next report earnings?

Next earnings date2026-08-10
Consensus EPS estimate-0.64 USD
Revenue estimaten/a

SION earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-02-0.46 USD-0.539 USD+14.7%Beat
2025-08-11-0.41 USD-0.68 USD+39.7%Beat
2025-05-12-0.62 USD-0.45 USD-37.8%Miss
2025-03-20-3.38 USD-0.57 USD-493%Miss
2024-11-27-0.92 USDn/an/an/a

Beat rate: 2/4 (50%) over reported quarters with consensus data.

SION valuation and analyst view

Trailing P/E-23.33
Trailing EPS-1.90475 USD
Price / book7.02
Dividend yield0.00%
Market cap2.04B
Analyst consensusBuy (5 buy / 1 hold / 1 sell)
Avg price target55 USD

Related research pages

Frequently asked questions

When is Sionna Therapeutics (SION)'s next earnings date?

Sionna Therapeutics is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.64 USD.

Did SION beat earnings last quarter?

In its 2026-03-02 report, SION posted EPS of -0.46 USD versus a -0.539 USD estimate — a beat of 14.7%.

What is SION's earnings track record?

Over the last 4 reported quarters with consensus data, SION beat estimates 2 times (50%).

What is SION's current P/E ratio and EPS?

SION trades at a trailing P/E of -23.33 on trailing EPS of -1.9047466826042234 USD.

What do analysts rate SION?

Analyst consensus is "Buy" across 7 ratings (0 strong buy, 5 buy, 1 hold, 1 sell, 0 strong sell). Average 12-month price target: 55 USD.